Wendy's to ban chickens with human antibiotics by 2017


LOS ANGELES:  Wendy's Co, the fifth-largest U.S. fast-food chain by revenue, will quit using chickens raised with antibiotics important to human health by 2017, the company told Reuters on Thursday.

Fast-food industry leader McDonald's Corp on Monday said it had completed its shift to using only using chickens raised without antibiotics important to human medicine, months ahead of its estimated March 2017 target.

Concern has been growing among public health experts, consumers and shareholders that the overuse of such drugs is contributing to rising numbers of life-threatening human infections from antibiotic-resistant bacteria dubbed "superbugs."

An estimated 70 percent of antibiotics important to human health are sold for use in meat and dairy production.

Veterinary use of antibiotics is legal. However, as the number of human infections from antibiotic-resistant bacteria increases, consumer advocates and public health experts have become more critical of the practice of routinely feeding antibiotics to chickens, cattle and pigs.

Wendy's and its chicken suppliers have been working to eliminate all antibiotics important to human medicine from chicken production, the company told Reuters on Thursday. As of June 2016, half of Wendy's chicken supply was raised without medically important antibiotics. Wendy's said it would be at 100 percent by next year.

Wendy's, which purchases more than 250 million pounds of chicken annually, also said it would commit to specific goals for the reduction of antibiotics important to humans in pork and beef production in 2017.

With regard to beef, Wendy's said it is engaged with academics and industry experts on work that includes trials for probiotics, vaccines, feed supplements and nutrition composition.

The company posted the new policies to its website on July 28 but did not otherwise publicize the change, before speaking with Reuters. - Reuters


Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Business News

Wall St set to open higher on tech boost, PCE data
US inflation rises in line with expectations in March
Gamuda Land announces retail partners for Gamuda Gardens
YNH reaffirms bondholders with remedied technical defaults
Ringgit ends firmer against US dollar
KPJ Healthcare partners with Trustr for AI-driven healthcare solutions
Homeritz stays positive amid economic challenges
Unisem expects performance boost amid semiconductor recovery
Gadang wins RM280mil data centre contract
S P Setia unveils Casaville single-storey bungalows in Setia EcoHill, Semenyih

Others Also Read